10-YEAR LONG-TERM SURVIVAL (LTS) OF INDUCTION (IND) CHEMOTHERAPY (CTX) WITH THREE CYCLES CISPLATIN(P)/PACLITAXEL(T) FOLLOWED BY CONCURRENT (CC) CHEMORADIATION (CTX/RTX) P/ETOPOSIDE (ETO)/45 GY (1.5 GY BID) PLUS SURGERY (S) - A MULTICENTER PHASE-II TRIAL (CISTAXOL).
JOURNAL OF THORACIC ONCOLOGY（2011）
关键词
NSCLC,Stage III,combined modality,Surgery
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要